Redox Biology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2025-06-10 addsalt 来自广东省

with editor 5天了，有机会送审嘛？

12 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2025-04-28 wangc 来自山东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：翻译后修饰;炎症
经验分享：2.10 submit to journal，当天with editor
2.11 under review
3.18 小修
3.27 接收

0 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2024-12-11 sucao 来自湖南省

没有想象中的容易，wang hong编辑，两个工作日拒稿

40 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2024-11-06 ms4000000265024223 来自山东省

偏重的研究方向：mitophagy;肿瘤;ROS
经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？

48 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2025-05-22 1222cc4dm61(暂无昵称) 来自四川省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：氧化还原方向，铁死亡、
经验分享：昨天投稿，今天就被通知转投

17 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2025-04-21 ms1000001176701898 来自浙江省

4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。

28 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2025-03-04 ms3000000630746382 来自山东省

偏重的研究方向：氧化还原信号分子
经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。

27 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2022-10-02 ms4000001640053712

投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！

152 11 举报

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2020-12-17 Franksix

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肾损伤;氧化应激;线粒体
经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。

111 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2268731, encodeId=56fa2268e31b4, content=with editor 5天了，有机会送审嘛？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88512491338, createdName=addsalt, createdTime=Tue Jun 10 13:11:03 CST 2025, time=2025-06-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2262654, encodeId=1749226265441, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：翻译后修饰;炎症 经验分享：2.10 submit to journal，当天with editor 2.11 under review 3.18 小修 3.27 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2feb5587016, createdName=wangc, createdTime=Mon Apr 28 23:32:37 CST 2025, time=2025-04-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266270, encodeId=54bc22662e08a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：氧化还原方向，铁死亡、 经验分享：昨天投稿，今天就被通知转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaa92312330, createdName=1222cc4dm61(暂无昵称), createdTime=Thu May 22 22:12:50 CST 2025, time=2025-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2261457, encodeId=50ac226145e6f, content=4.2submit to journal，4.2with editor，到现在没动静，本以为会非常快的，等麻了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcf46550494, createdName=ms1000001176701898, createdTime=Mon Apr 21 20:25:28 CST 2025, time=2025-04-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254487, encodeId=3eef225448e75, content=偏重的研究方向：氧化还原信号分子 经验分享：一审一个月，给了重投，一个月后修回去二审20天接受，第一次投稿就上传了原始数据。整体效率还算可以，就是editor稍微慢点都是十天左右才送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153d8737967, createdName=ms3000000630746382, createdTime=Tue Mar 04 06:20:49 CST 2025, time=2025-03-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091460, encodeId=e9a22091460ef, content=投稿后立刻显示已投递到杂志，几小时后，（也就在投稿当天）显示under review。没关注到是否有with editor过程。track 投稿，一直显示是：邀请审稿人。接近10天了，还是0位审稿人接收邀请。请问有经验的战友，这是什么情况？找不到审稿人，还是这个track系统更新滞后😌。谢谢，祝大家假期愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b9a8133033, createdName=ms4000001640053712, createdTime=Sun Oct 02 11:59:58 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908751, encodeId=b65a908e5149, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肾损伤;氧化应激;线粒体 经验分享：2020年的09.29投稿，10.09 under review（送外审），10.28号状态变为required reviews completed, 10.29号再次变为under review，估计是追加外审。再次经历审稿的等待，11.11号给出意见，给一个月时间小修。经过两周的修改回复审稿意见（response letter），11.29号小修修回，两周后（12.14号）给出最终意见，accepted. 经历两次的审稿期间等待的煎熬确实难受，不过结果是好的，整体还算顺利。特此纪念一下我的第一篇五分以上的文章，明年就要破十分了，越来越难中了。不过还是要努力，万一有机会呢，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Thu Dec 17 02:27:02 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省)]

2023-08-18 ms8000000123523430 来自安徽省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：氧化应激;肾损伤
经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。

142 5 举报

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务